Apollo Hospitals will leverage AI for Heart

New Delhi: Apollo Hospitals’ avowed aim of fighting against tsunami of Non Communicable Diseases (NCD) including cardiovascular disease has got a force multiplier in Microsoft. This partnership will lead to the prediction of the risk of cardiovascular disease in the Indian population.

As part of Microsoft’s AI Network for Healthcare initiative, Microsoft India and Apollo Hospitals Group have joined hands to set up a National Clinical Coordination Committee (NCCC) for AI-powered Cardiovascular Disease Risk Score API.

According to a press release NCCC will assist the core team at Apollo Hospitals and Microsoft by providing guidance on all cardiology and cardiovascular-related artificial intelligence projects; insights on developing clinical algorithm and treatment guidelines based on the inferences of national, multi-centre prospective study, a release said here.

‘The NCCC is a great step forward as part of our partnership with Apollo. We are also engaging global consortium partners to scale the AI-powered API (application programme interface),’ Microsoft, Cloud & Enterprise, Corporate Vice President, Anil Bhansali said,

‘We have already received approval for a pilot study and we hope that the findings will enable physicians to better understand the causes of CVDs in Indian population,’ he further said.

Speaking about the National Clinical Coordination Committee, Apollo Hospitals Group, Joint Managing Director, Sangita Reddy, said, ‘The NCCC will help us immensely in our fight against the rising tsunami of Non-Communicable Diseases (NCDs).’

According to the release, cardiovascular diseases (CVDs) are the biggest cause of mortality in India with nearly 25 percent mortalities in the age group of 25 to 69 years. The condition also seems to affect Indians at least a decade earlier as compared to the Europeans.

Given the high prevalence of CVDs among Indians, Apollo Hospitals and Microsoft India, in 2018, launched the first ever AI-powered CVD Risk Score API, designed specifically to predict the risk of cardiovascular disease in the Indian population, it said.

Built on Microsoft Azure, the API aims to determine a more accurate CVD risk score for the Indian population taking into consideration risk factors including lifestyle attribute like diet, tobacco and smoking preferences, physical activity and psychological stress and anxiety.

Related Posts

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

AiMeD welcomes the move long overdue to boost India’s Regulatory Framework New Delhi: 21 Drug Inspectors have been promoted to Assistant Drugs Controllers (India) under CDSCO. It was long unmet…

Yashoda Medicity lifts Benchmark in Critical Care to New High

With the introduction of North India’s first Advanced VitalGo Total Lift Bed Technology Ghaziabad/ New Delhi: In an ideal hospital, critical care is most paramount and it is also the…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

Sun Pharma will Need HC Nod for Semaglutide Tablet Launch

Sun Pharma will Need HC Nod for Semaglutide Tablet Launch

Bombay HC tells Maharashtra FDA to be ‘judicious’ after Cadila challenges order to ban sale of some medicines

Bombay HC tells Maharashtra FDA to be ‘judicious’ after Cadila challenges order to ban sale of some medicines

‘Erring pharma companies’: Over 1,000 cough syrup manufacturers undergo intense audits

‘Erring pharma companies’: Over 1,000 cough syrup manufacturers undergo intense audits

Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses

Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses